Béatrice Desvergne Selected Research

Dyslipidemias (Dyslipidemia)

2/2006

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Béatrice Desvergne Research Topics

Disease

11	Inflammation (Inflammations) 01/2019 - 02/2004
8	Obesity 12/2012 - 04/2002
5	Wounds and Injuries (Trauma) 05/2005 - 10/2002
4	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2002
4	Insulin Resistance 06/2008 - 11/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2006 - 04/2002
3	Neoplasms (Cancer) 05/2007 - 06/2002
3	Metabolic Diseases (Metabolic Disease) 08/2006 - 08/2005
2	Lipodystrophy 01/2018 - 12/2012
2	Pulmonary Hypertension 03/2010 - 02/2006
2	Ischemia 05/2007 - 08/2005
2	Hypoglycemia (Reactive Hypoglycemia) 09/2006 - 01/2005
2	Body Weight (Weight, Body) 10/2004 - 04/2002
1	Chronic Disease (Chronic Diseases) 11/2021
1	Osteoporosis 01/2021
1	Hyperphagia (Overeating) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Hyperglycemia 01/2018
1	Renal Insufficiency (Renal Failure) 01/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017
1	Carcinogenesis 01/2015
1	Postmenopausal Osteoporosis 05/2013
1	Infections 01/2012
1	Sepsis (Septicemia) 12/2010
1	Endotoxemia 12/2010
1	Septic Shock (Toxic Shock Syndrome) 12/2010
1	Shock 12/2010
1	Pneumonia (Pneumonitis) 12/2010
1	Pulmonary Arterial Hypertension 03/2010
1	Hypoxia (Hypoxemia) 03/2010
1	Cardiomegaly (Heart Hypertrophy) 03/2010
1	Nervous System Diseases (Neurological Disorders) 01/2008
1	Leukemia 12/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2007
1	Nevus (Nevi) 05/2007
1	Ischemic Stroke 05/2007
1	Melanoma (Melanoma, Malignant) 05/2007
1	Brain Ischemia (Cerebral Ischemia) 05/2007
1	Papilloma (Papillomatosis) 05/2007
1	Stroke (Strokes) 05/2007
1	Dyslipidemias (Dyslipidemia) 02/2006
1	Acute Kidney Injury (Acute Renal Failure) 08/2005
1	Necrosis 08/2005
1	Kidney Calculi (Kidney Stone) 06/2005
1	Primary hyperoxaluria type 2 06/2005
1	Colitis 04/2005
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2005
1	Starvation 01/2005

Drug/Important Bio-Agent (IBA)

15	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 06/2002
14	PPAR-betaIBA 03/2010 - 10/2002
10	PPAR gammaIBA 05/2010 - 11/2002
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2002
5	LipidsIBA 01/2019 - 04/2002
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2015 - 04/2005
5	PPAR alphaIBA 02/2010 - 05/2004
4	LigandsIBA 02/2006 - 11/2002
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 04/2006
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2010 - 01/2005
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 05/2005
2	CreatinineIBA 01/2017 - 08/2005
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 12/2010 - 03/2010
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2010 - 02/2006
2	PPAR deltaIBA 06/2008 - 12/2007
2	Pharmaceutical PreparationsIBA 08/2006 - 04/2005
2	CholesterolIBA 08/2005 - 04/2002
2	Insulin (Novolin)FDA Link 11/2002 - 04/2002
1	AdipoRonIBA 01/2021
1	Amino Acids FDA Link 01/2019
1	AntibodiesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013
1	lipineIBA 12/2012
1	vasostatinIBA 01/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2010
1	Glycogen Synthase KinasesIBA 12/2010
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2010
1	Endothelin Receptor AntagonistsIBA 03/2010
1	Phosphodiesterase 5 InhibitorsIBA 03/2010
1	Diethylhexyl Phthalate (DEHP)IBA 02/2010
1	mono-(2-ethylhexyl)phthalateIBA 05/2009
1	AntioxidantsIBA 01/2008
1	Neuroprotective AgentsIBA 01/2008
1	Retinoid X Receptor alphaIBA 05/2007
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2007
1	treprostinil FDA Link 02/2006
1	4- (3- (2- propyl- 3- hydroxy- 4- acetyl)phenoxy)propyloxyphenoxy acetic acidIBA 08/2005
1	OxalatesIBA 06/2005
1	glyoxylate reductaseIBA 06/2005
1	Hydroxypyruvate ReductaseIBA 06/2005
1	EnzymesIBA 06/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2005
1	Chemotactic FactorsIBA 05/2005
1	Mesalamine (Mesalazine)FDA LinkGeneric 04/2005
1	Biological ProductsIBA 11/2004

Therapy/Procedure

2	Therapeutics 03/2010 - 04/2002
1	Precision Medicine 11/2021
1	Punctures 12/2010
1	Ligation 12/2010